Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same
申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
公开号:EP0123254A1
公开(公告)日:1984-10-31
New triazine derivatives represented by the formula:
wherein
R' is hydrogen or halogen;
R2 is a hydroxy, protected hydroxy, amino, cyano, mercapto, lower alkylthio, arylthio, sulfamoyl, lower alkylsulfonylamino, lower alkylureido, arylureido, lower alkyl-thioureido, aryl-thioureido, lower alkenoylamino, lower alkoxycarbonylamino, lower alkoxy (thiocarbonyl) thio, or cyclic or acyclic alkanoylamino
in which the cyclic and acyclic alkanoylamino group may have a substituent selected from lower alkoxy, aryl, hydroxyaryl; and protected hydroxyaryl; and
X is O or S;
and pharmaceutically acceptable salt thereof, which are useful in the treatment of hypertension, thrombosis and ulcer in human beings and animals.
由以下式子表示的新型三嗪衍
生物
其中
R' 是氢或卤素;
R2是羟基、受保护的羟基、
氨基、
氰基、巯基、低级烷
硫基、芳基
硫基、
氨基磺酰基、低级烷基磺酰基
氨基、低级烷基
脲基、芳基
脲基、低级烷基
硫脲基、芳基
硫脲基、低级烯酰胺基、低级烷氧基羰基
氨基、低级烷氧基(
硫代羰基)
硫基或环状或无环状烷酰胺基。
其中环状和非环状烷酰基
氨基可具有选自低级烷氧基、芳基、羟基芳基和受保护羟基芳基的取代基;以及
X 是 O 或 S;
及其药学上可接受的盐,可用于治疗人类和动物的高血压、血栓和溃疡。